HUE051549T2 - Di (fenilpropanoid) glicerin származékai rák kezelésére - Google Patents
Di (fenilpropanoid) glicerin származékai rák kezeléséreInfo
- Publication number
- HUE051549T2 HUE051549T2 HUE10821532A HUE10821532A HUE051549T2 HU E051549 T2 HUE051549 T2 HU E051549T2 HU E10821532 A HUE10821532 A HU E10821532A HU E10821532 A HUE10821532 A HU E10821532A HU E051549 T2 HUE051549 T2 HU E051549T2
- Authority
- HU
- Hungary
- Prior art keywords
- phenylpropanoid
- cancer
- treatment
- glycerol derivatives
- glycerol
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000002314 glycerols Chemical class 0.000 title 1
- 229930015704 phenylpropanoid Natural products 0.000 title 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25028709P | 2009-10-09 | 2009-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE051549T2 true HUE051549T2 (hu) | 2021-10-28 |
Family
ID=43352967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE10821532A HUE051549T2 (hu) | 2009-10-09 | 2010-10-08 | Di (fenilpropanoid) glicerin származékai rák kezelésére |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9061993B2 (enExample) |
| EP (1) | EP2486026B1 (enExample) |
| JP (1) | JP5529280B2 (enExample) |
| CN (1) | CN102264713A (enExample) |
| BR (1) | BR112012008204A2 (enExample) |
| CA (1) | CA2715662C (enExample) |
| CY (1) | CY1123161T1 (enExample) |
| DK (1) | DK2486026T3 (enExample) |
| ES (1) | ES2810906T3 (enExample) |
| HR (1) | HRP20201217T1 (enExample) |
| HU (1) | HUE051549T2 (enExample) |
| LT (1) | LT2486026T (enExample) |
| MX (1) | MX360417B (enExample) |
| MY (2) | MY160378A (enExample) |
| PL (1) | PL2486026T3 (enExample) |
| PT (1) | PT2486026T (enExample) |
| RS (1) | RS60667B1 (enExample) |
| SI (1) | SI2486026T1 (enExample) |
| SM (1) | SMT202000428T1 (enExample) |
| WO (1) | WO2011041907A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| US9402834B2 (en) | 2014-10-21 | 2016-08-02 | Ions Pharmaceutical S.À R.L. | Human therapeutic agents |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857873A (en) | 1974-02-11 | 1974-12-31 | Warner Lambert Co | 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols |
| CH648753A5 (de) * | 1981-07-22 | 1985-04-15 | Givaudan & Cie Sa | Lichtschutzmittel. |
| CN1238333C (zh) * | 2003-06-18 | 2006-01-25 | 清华大学 | 药物化合物菠萝酰酯及其制备方法和用途 |
| US7713556B2 (en) | 2006-12-08 | 2010-05-11 | Henry Lowe | Anti-tumor and anti-inflammatory extracts of plant biomass and their uses |
| DK2104659T3 (en) * | 2007-01-08 | 2015-11-02 | Allianz Pharmascience Ltd | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
| TWI383251B (zh) * | 2008-01-16 | 2013-01-21 | Eternal Chemical Co Ltd | 感光型聚醯亞胺 |
| KR101074149B1 (ko) * | 2009-04-15 | 2011-10-17 | 한밭대학교 산학협력단 | 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도 |
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
-
2010
- 2010-10-08 SI SI201032026T patent/SI2486026T1/sl unknown
- 2010-10-08 DK DK10821532.8T patent/DK2486026T3/da active
- 2010-10-08 MY MYPI2012001601A patent/MY160378A/en unknown
- 2010-10-08 JP JP2012532432A patent/JP5529280B2/ja not_active Expired - Fee Related
- 2010-10-08 ES ES10821532T patent/ES2810906T3/es active Active
- 2010-10-08 PL PL10821532T patent/PL2486026T3/pl unknown
- 2010-10-08 LT LTEP10821532.8T patent/LT2486026T/lt unknown
- 2010-10-08 CN CN201080003781XA patent/CN102264713A/zh active Pending
- 2010-10-08 US US12/901,113 patent/US9061993B2/en active Active
- 2010-10-08 RS RS20200931A patent/RS60667B1/sr unknown
- 2010-10-08 SM SM20200428T patent/SMT202000428T1/it unknown
- 2010-10-08 EP EP10821532.8A patent/EP2486026B1/en active Active
- 2010-10-08 HU HUE10821532A patent/HUE051549T2/hu unknown
- 2010-10-08 WO PCT/CA2010/001613 patent/WO2011041907A1/en not_active Ceased
- 2010-10-08 MX MX2012004160A patent/MX360417B/es active IP Right Grant
- 2010-10-08 CA CA2715662A patent/CA2715662C/en active Active
- 2010-10-08 PT PT108215328T patent/PT2486026T/pt unknown
- 2010-10-08 MY MYPI2016000361A patent/MY187188A/en unknown
- 2010-10-08 BR BR112012008204A patent/BR112012008204A2/pt not_active Application Discontinuation
- 2010-10-08 HR HRP20201217TT patent/HRP20201217T1/hr unknown
-
2015
- 2015-05-17 US US14/714,318 patent/US10052301B2/en active Active
-
2020
- 2020-08-05 CY CY20201100724T patent/CY1123161T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT2486026T (lt) | 2020-09-10 |
| PL2486026T3 (pl) | 2020-11-02 |
| HRP20201217T1 (hr) | 2020-12-11 |
| MX2012004160A (es) | 2012-09-07 |
| SI2486026T1 (sl) | 2020-10-30 |
| CY1123161T1 (el) | 2021-10-29 |
| WO2011041907A1 (en) | 2011-04-14 |
| MY160378A (en) | 2017-03-15 |
| US10052301B2 (en) | 2018-08-21 |
| ES2810906T3 (es) | 2021-03-09 |
| PT2486026T (pt) | 2020-08-21 |
| EP2486026A1 (en) | 2012-08-15 |
| CA2715662A1 (en) | 2010-12-14 |
| US9061993B2 (en) | 2015-06-23 |
| RS60667B1 (sr) | 2020-09-30 |
| MX360417B (es) | 2018-10-25 |
| CN102264713A (zh) | 2011-11-30 |
| SMT202000428T1 (it) | 2020-09-10 |
| BR112012008204A2 (pt) | 2017-07-18 |
| CA2715662C (en) | 2013-05-07 |
| US20110086912A1 (en) | 2011-04-14 |
| JP5529280B2 (ja) | 2014-06-25 |
| EP2486026A4 (en) | 2015-07-01 |
| US20150246014A1 (en) | 2015-09-03 |
| DK2486026T3 (da) | 2020-08-17 |
| EP2486026B1 (en) | 2020-06-24 |
| MY187188A (en) | 2021-09-09 |
| JP2013507327A (ja) | 2013-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223201A (en) | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer | |
| DK3289876T3 (da) | Forbindelser til behandling af cancer | |
| BR112012005594A2 (pt) | tratamento de câncer | |
| HUE054495T2 (hu) | Rák kezelésére szolgáló készítmény | |
| HRP20150477T8 (hr) | Postupci dobivanja derivata kinazolona | |
| DK2121139T3 (da) | Formulations for cancer treatment | |
| DK2195015T3 (da) | Sammensætning til behandling af prostatacancer | |
| EP2470527A4 (en) | ETHER-benzotriazole | |
| PL2733492T3 (pl) | Sposób wykrywania nowotworów | |
| EP2460538A4 (en) | TUMOR METASTASIS INHIBITORS | |
| DK3517534T3 (da) | Forbindelser, der er anvendelige til behandling af cancer | |
| PL3443957T3 (pl) | Związki i kompozycje stosowane w leczeniu nowotworów | |
| DK3246042T3 (da) | Lægemiddelresistent immunterapi til behandling af cancer | |
| BRPI1010874A8 (pt) | composição para o tratamento de câncer de próstata | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| IL220386B (en) | Compositions for the liquidation of tumors and uses thereof | |
| DK2452189T3 (da) | Fremgangsmåde til identifikation af forbindelser til behandling af cancer | |
| BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
| EP2283862A4 (en) | CANCER AGENT | |
| BR112012002797A2 (pt) | tratamento de câncer de próstata | |
| IL226246A0 (en) | Methods of treating cancer | |
| SMT201600076B (it) | Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo | |
| SMT201700056B (it) | Fosfaplatine e relativo utilizzo per il trattamento di cancro | |
| HUE038563T2 (hu) | Rák kezelési eljárás | |
| BRPI1009435A2 (pt) | tratamento para câncer no pâncreas |